Chief Executive John Lee said he was confident the SAR would grasp the opportunities brought about by Beijing’s ...
PGIM Jennison Health Sciences Fund outperformed its index in Q4 2025, led by Eli Lilly and Arcutis. Read the full analysis for more details.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果